Pharmacokinetics of Intranasal and Intratracheal Pentoxifylline in Rabbits

Study Objective. To evaluate the disposition of pentoxifylline and its metabolite, lisofylline, in New Zealand rabbits after two alternative routes of administration, intranasal and intratracheal.

[1]  Kim G. Adcock,et al.  Use of liquid chromatography-tandem mass spectrometry for the analysis of pentoxifylline and lisofylline in plasma. , 2005, Biomedical chromatography : BMC.

[2]  R. L. Zollner,et al.  Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  A. Zaritsky,et al.  Early postnatal dexamethasone treatment and increased incidence of cerebral palsy , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[4]  T. Krakauer.  Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. , 2000, Immunopharmacology.

[5]  D. Woodrum,et al.  Early Postnatal Dexamethasone Increases the Risk of Focal Small Bowel Perforation in Extremely Low Birth Weight Infants , 1999, Journal of Perinatology.

[6]  G. Fantuzzi,et al.  Effects of lisofylline on hyperoxia-induced lung injury. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[7]  H. Hörnchen,et al.  Early versus late dexamethasone treatment in preterm infants at risk for chronic lung disease: a randomized pilot study , 1999, European Journal of Pediatrics.

[8]  U. Costabel,et al.  Pentoxifylline Inhibits TNF- α Production from Human Alveolar Macrophages , 1999 .

[9]  C. D’Angio,et al.  Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. , 1999, Experimental lung research.

[10]  N. Poulakis,et al.  The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. , 1999, Respiratory medicine.

[11]  A. Coates,et al.  Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. , 1998, The Journal of pediatrics.

[12]  T. Yeh,et al.  Early dexamethasone therapy in preterm infants: a follow-up study. , 1998, Pediatrics.

[13]  L. Lilien,et al.  A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. , 1997, Pediatrics.

[14]  U. Costabel,et al.  Smoker's lung transplanted to a nonsmoker. Long-term detection of smoker's macrophages. , 1997, American journal of respiratory and critical care medicine.

[15]  B. Hollis,et al.  Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. , 1997, The Journal of pediatrics.

[16]  P. Zabel,et al.  Pentoxifylline in treatment of sarcoidosis. , 1997, American journal of respiratory and critical care medicine.

[17]  C. D’Angio,et al.  Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. , 1997, The American journal of physiology.

[18]  T. Yeh,et al.  Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation , 1997, Pediatric pulmonology.

[19]  M. Guenounou,et al.  Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline , 1996 .

[20]  Hans-Dieter Volk,et al.  Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs , 1995 .

[21]  W. Graninger,et al.  Effect of various pentoxiphylline concentrations on macrophage inflammatory protein 1 alpha production , 1995, Antimicrobial agents and chemotherapy.

[22]  J. Pittet,et al.  The Effect of Pentoxifylline on Acid‐induced Alveolar Epithelial Injury , 1995, Anesthesiology.

[23]  R. Knobler,et al.  Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. , 1994, Immunology.

[24]  I. Chaudry,et al.  Pentoxifylline attenuates oxygen-induced lung injury. , 1994, The Journal of surgical research.

[25]  José Raúl Rodríguez Rodríguez,et al.  Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-alpha in human type II pneumocytes. , 1994, American journal of respiratory and critical care medicine.

[26]  D. Fyfe,et al.  Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia. , 1993, American heart journal.

[27]  M. Trese,et al.  Severe retinopathy of prematurity and steroid exposure. , 1992, Pediatrics.

[28]  S. Fisher,et al.  Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. , 1992, The Journal of pediatrics.

[29]  Y. Yamashiro,et al.  Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. , 1992, Archives of disease in childhood.

[30]  J. Norton,et al.  Pentoxifylline suppression of tumor necrosis factor gene transcription. , 1991, Surgery.

[31]  M. Yoder,et al.  Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. , 1991, The American review of respiratory disease.

[32]  R. Popp,et al.  Late pulmonary sequelae of bronchopulmonary dysplasia. , 1990, The New England journal of medicine.

[33]  T. Yeh,et al.  Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. , 1990, The Journal of pediatrics.

[34]  Jiahuai Han,et al.  Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway , 1990, The Journal of experimental medicine.

[35]  L. Papile,et al.  Long-term follow-up of bronchopulmonary dysplasia. , 1986, The Journal of pediatrics.

[36]  R. Sauve,et al.  Long-term morbidity of infants with bronchopulmonary dysplasia. , 1985, Pediatrics.

[37]  J. Miners,et al.  Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography. , 1981, Journal of chromatography.

[38]  A. Maynard,et al.  Gastroduodenal perforation. , 1968, Archives of surgery.

[39]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.